Alterations in NFκB activation in T lymphocytes of patients with renal cell carcinoma

Journal of the National Cancer Institute

Volumn 91, Issue 8, 1999, Pages 718-721

  Uzzo, Robert G ^a   Clark, Peter E ^b   Rayman, Patricia ^b   Bloom, Tracy ^b   Rybicki, Lisa ^b   Novick, Andrew C ^b   Bukowski, Ronald M ^b   Finke, James H ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER IMMUNOLOGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE REPRESSION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TUMOR IMMUNITY; IMMUNOLOGY; KIDNEY TUMOR; METABOLISM;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; LYMPHOCYTE ACTIVATION; NF-KAPPA B; T-LYMPHOCYTES;

EID: 0033590799     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.8.718     Document Type: Article

References (24)

1. Finke JH, Rayman P, Hart L, Alexander JP, Edinger MG, Tubbs RR, et al. Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation. J Immunother Emphasis Tumor Immunol 1994;15: 91-104.
2. Miescher S, Stoeck M, Qiao L, Barras C, Barrelet L, von Fliedner V. Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors. Cancer Res 1988;48(24 Pt 1): 6992-8.
3. Loeffler CM, Smyth MJ, Longo DL, Kopp WC, Harvey LK, Tribble HR, et al. Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells. J. Immunol 1992; 149:949-56.
4. Bukowski RM, Rayman P, Uzzo R, Bloom T, Sandstrom K, Peereboom D, et al. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy. Clin Cancer Res 1998;4: 2337-47.
5. Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, et al. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res 1993;53: 1380-7.
6. Miescher SM, Stoeck M, Qiao L, Barras C, Barrelet L, Von Fliedner V. Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression. Int J Cancer 1988; 42:659-66.
7. Wang Q, Redovan C, Tubbs R, Olencki T, Klein E, Kudoh S, et al. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor infiltrating lymphocytes. Int J Cancer 1995;61:780-5.
8. Ochoa AC, Longo DL. Alteration of signal transduction in T cells from cancer patients. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Important advances in oncology 1995. Philadelphia (PA): Lippincott; 1995. p. 43-54.
9. Ghosh P, Sica A, Young HA, Ye J, Franco JL, Wiltrout RH, et al. Alterations in NF κB/ Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. Cancer Res 1994;54: 2969-72.
10. Li X, Liu J, Park JK, Hamilton TA, Rayman P, Klein E, et al. T cells from renal cell carcinoma patients exhibit an abnormal pattern of κB-specific DNA binding activity, a preliminary report. Cancer Res 1994;54: 5424-9.
11. Ullman KS, Northrop JP, Verweij CL, Crabtree GR. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu Rev Immunol 1990;8:421-52.
12. Nolan GP, Baltimore D. The inhibitory ankyrin and activator Rel proteins. Curr Opin Gene Dev 1992;2:211-20.
13. May MJ, Ghosh S. Signal transduction through NF-κB. Immunol Today 1998;19: 80-8.
14. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell 1996;87:13-20.
15. Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NFκB leads to multifocal defects in immune responses. Cell 1996;80:321-30.
16. Beg AA, Baltimore D. An essential role for NF-kappa B in preventing TNF-alpha induced cell death. Science 1996;274: 782-4.
17. Wang CY, Mayo MW, Baldwin AS Jr. TNF-and cancer therapy induced apoptosis: potentiation by inhibition of NF-κB. Science 1996; 274:784-7.
18. Ling W, Rayman P, Uzzo R, Clark P, Kim HJ, Tubbs R, et al. Impaired activation of NFκB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor. IκBα. Blood 1998;92: 1334-41.
19. Kolenko V, Wang Q, Riedy MC, O'Shea J, Ritz J, Cathcart MK, et al. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas. J Immunol 1997;159:3057-67.
20. Finke JH, Ferrone S, Frey A, Mufson A, Ochoa A. Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol Today. In press 1999.
21. Kono K, Salazar-Onfray F, Petersson M, Hansson J, Masucci G, Wasserman K, et al. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity. Eur J Immunol 1996; 26:1308-13.
22. Rabinowich H, Reichert TE, Kashii Y, Gastman BR, Bell MC, Whiteside TL. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. J Clin Invest 1998;101:2579-88.
23. Otsuji M, Kimura Y, Aoe T, Okamoto Y, Saito T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci U S A 1996;93: 13119-24.
24. Uzzo RG, Rayman P, Kolenko V, Clark PE, Bloom T, Ward AM, et al. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res. In press 1999.